COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
eGene Announces Its HDA-GT12(TM) System That Shows Compatibility of Detecting Influenza A Virus, Known as the Avian Flu Virus
IRVINE, Calif., May 04, 2006 (BUSINESS WIRE) -- eGene Inc. (OTCBB:EGEI), developers of rapid DNA analyzers, announced today that its HDA-GT12(TM) Genetic Analyzer shows compatibility of detecting the influenza A virus, commonly known as the avian flu virus. The automatic analysis process is less than six minutes. The company has demonstrated that its system platform can handle 12 RT-PCR amplified virus samples in six minutes, or at a sample analysis rate of two samples per minute. As an acute respiratory infection, rapid detection of the influenza A virus is important. "The virus naturally infects humans and other mammalian species such as swine, horse and avian species," said Dr. Ming Liu, acting CEO of the company. "The concerns of a human outbreak of the avian influenza virus have raised significant concerns. Our system can rapidly detect whether we are dealing with an ordinary flu strain or the more serious avian strain. Furthermore, genetic analysis is one of the effective ways to determine whether the virus has mutated to a point where it is dangerous to humans. The need to perform this analysis rapidly cannot be understated in today's world where an airplane ride can transmit a virus thousands of miles in a short period of time."
The HDA-GT12 system uses a consumable multi-channel cartridge that can be used to detect multiple influenza samples simultaneously. The cartridge is engaged to eGene's system and can automatically inject and analyze 12 DNA samples at the same time for results available in six minutes, or for 96 samples from a PCR plate for results available in 50 minutes -- less than an hour.
"This automated and affordable system can be easily operated for avian influenza virus detection," said Dr. Liu.
He noted that eGene recently tested its system utilizing the reagents from In-Vitro Diagnostic FluAVision kits provided by DNA Technology A/S (Denmark). Positive control of influenza A from the testing kit was used for amplification and analyzed with the eGene HDA-GT12 system.
Previously, eGene explained that its analyzer, if placed in airports and other ports of entry throughout the world, can be used to determine if the flu virus is present in the DNA samples of travelers entering -- or leaving -- a given locale.
"The fact that our compact, low-cost, automated digital genetic analysis system platform can do the detection and analysis work in a short time means that should a flu pandemic break out, our system could easily detect and notify officials of a virus carrier who may not be exhibiting physical symptoms of the flu. This is very important, because with illnesses like the flu, the virus is already present and multiplying even in the absence of physical symptoms," explained Dr. Liu. "This could potentially stop the spread of the flu."
eGene currently sells its HDA-GT12 system in more than 100 hospitals and research centers worldwide, and is looking to expand U.S. distribution.
The HDA-GT12(TM) Genetic Analyzer analyzes the genetic fingerprints of living organisms through the microsatellites AFLP and RFLP. It performs fast DNA sample screening and high-resolution DNA fragment analysis (2-5bp). The system also analyzes the quality and quantity of total RNA and cRNA, determines the efficiency of cRNA and cDNA amplification reactions and ensures quality of fragmented cRNA. The company sells cartridges that are specific to the type of analysis to be performed. All data is then received in digital form for appropriate transmission and storage.
About eGene Inc.
eGene Inc. (www.egeneinc.com) focuses its core technologies of capillary electrophoresis, microfluidics, liquid handling and automation to develop and manufacture low-cost microfluidic, miniaturized digital genetic analyzer systems, software and consumables for biological materials testing applications. These products detect, quantify, identify and characterize DNA and RNA at high rates of specificity and sensitivity while automating routine and non-routine laboratory and industrial procedures critical to product safety, development quality and productivity.
his press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are made based on management's current expectations and beliefs. Actual results may vary from those currently anticipated based upon a number of factors. The company undertakes no obligation to release publicly any revision, which may be made to reflect events or circumstances after the date hereof.
SOURCE: eGene Inc.
CONTACT: Martin E. Janis & Company Inc. for eGene Inc. Beverly Jedynak, 312-943-1100, ext. 12 bjedynak*janispr.com
Copyright Business Wire 2006
-0-
KEYWORD: United States North America California INDUSTRY KEYWORD: Health Genetics Infectious Diseases Medical Devices Research & Science SUBJECT CODE: Product/Service
Search for Dun & Bradstreet reports on this company.
IP: Logged |
posted
Low float, the 52 week high is over $2. This product will catch allot of attention, especially now. I would say over $5 longer term.
IP: Logged |
posted
This really could be a gold mine. There system is effective in 6 minutes. Coupled with it being low cost, I think every hospital in the country will own many of them. This stock is very attractive. I think the orders are about to pour in. Every professional guarantees we are less than 2 years away from an outbreak. Scary, but profitable for this company.
IP: Logged |
posted
we already have detected the flu! LOL its spreading and we hear the news everyday of reports, who needs egei? we need STTK, contain the problem
IP: Logged |
Rochester, NY, May 05, 2006 (M2 PRESSWIRE via COMTEX) -- OTCStockExchange.com's "Stock Watch Alert" this morning are Marmion Industries Corp (OTCBB: MMIO), W2 Energy Inc. (Pink Sheets: WWEN), eGene Inc. (OTCBB: EGEI), Park City Group, Inc. (OTCBB: PKCY). Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com !
Marmion Industries Corp announced the signing of a two year purchasing-pricing agreement beginning June 1st of 2006 with Powell Industries, a publicly traded company on the NASDAQ National Market system that has been a steady customer of Marmion Industries Corp. for over three years. "This agreement, that is potentially worth more than $600,000.00 over the term to supply equipment, shows that we are bringing our products to market in a fashion that appeals to our repeat customers and their needs. Marmion Industries Corp. has been a reliable supplier of environmental systems to the companies that build the new critical industrial faculties and control centers," said W.H. Marmion, president of Marmion Industries Corp. "We are highly pleased with our repeat customer base and are currently in negotiations with other companies to bring additional products to market."
Marmion Industries Corp ( http://www.marmionair.com ) is a specialty company that manufactures and markets explosion-proof air conditioners, refrigeration systems, chemical filtration systems and building pressurizers. The explosion-proof market encompasses industries including oil and gas exploration and production, chemical plants, graineries and fuel storage depots. Additionally, there is significant demand for these systems anywhere sensitive computer systems and analyzation equipment is located. Recognized by the Texas Dept. of Licensing and Regulation (TACLA019367C) as a contractor in the field of Heating Ventilation and Air Conditioning, as well as the Louisiana State Licensing Board of Contractors (Lic. No. 44001) as a contractor in the field of Commercial Heatihng Ventilation and Air Conditions and Sheetmetal. The Company commenced residential and commercial HVAC service operation in Texas in 1998 and has since provided specialty service to Fortune 500 clientele.
W2 Energy Inc., a developer of Green Energy, is pleased to announce it will file its financials under a Form 10 and begin regular reporting. Upon filing of the financials W2 Energy will make application to the AMEX for listing. Mr. Michael McLaren CEO states, ''We have finished with the restructuring of the company and are satisfied that we can move ahead with a strong foundation and a clear focus to execute our business plan to the fullest.'' He also stated, ''We all look forward to listing on the AMEX building shareholder value, market capital and executing strategic acquisitions that will complement our already impressive portfolio of technologies, patents and commercial applications.''
eGene Inc., developers of rapid DNA analyzers, announced that its HDA-GT12(TM) Genetic Analyzer shows compatibility of detecting the influenza A virus, commonly known as the avian flu virus. The automatic analysis process is less than six minutes. The company has demonstrated that its system platform can handle 12 RT-PCR amplified virus samples in six minutes, or at a sample analysis rate of two samples per minute.
As an acute respiratory infection, rapid detection of the influenza A virus is important. "The virus naturally infects humans and other mammalian species such as swine, horse and avian species," said Dr. Ming Liu, acting CEO of the company. "The concerns of a human outbreak of the avian influenza virus have raised significant concerns. Our system can rapidly detect whether we are dealing with an ordinary flu strain or the more serious avian strain. Furthermore, genetic analysis is one of the effective ways to determine whether the virus has mutated to a point where it is dangerous to humans. The need to perform this analysis rapidly cannot be understated in today's world where an airplane ride can transmit a virus thousands of miles in a short period of time."
The HDA-GT12 system uses a consumable multi-channel cartridge that can be used to detect multiple influenza samples simultaneously. The cartridge is engaged to eGene's system and can automatically inject and analyze 12 DNA samples at the same time for results available in six minutes, or for 96 samples from a PCR plate for results available in 50 minutes -- less than an hour.
"This automated and affordable system can be easily operated for avian influenza virus detection," said Dr. Liu.
He noted that eGene recently tested its system utilizing the reagents from In-Vitro Diagnostic FluAVision kits provided by DNA Technology A/S (Denmark). Positive control of influenza A from the testing kit was used for amplification and analyzed with the eGene HDA-GT12 system.
Previously, eGene explained that its analyzer, if placed in airports and other ports of entry throughout the world, can be used to determine if the flu virus is present in the DNA samples of travelers entering -- or leaving -- a given locale.
"The fact that our compact, low-cost, automated digital genetic analysis system platform can do the detection and analysis work in a short time means that should a flu pandemic break out, our system could easily detect and notify officials of a virus carrier who may not be exhibiting physical symptoms of the flu. This is very important, because with illnesses like the flu, the virus is already present and multiplying even in the absence of physical symptoms," explained Dr. Liu. "This could potentially stop the spread of the flu."
eGene currently sells its HDA-GT12 system in more than 100 hospitals and research centers worldwide, and is looking to expand U.S. distribution.
The HDA-GT12(TM) Genetic Analyzer analyzes the genetic fingerprints of living organisms through the microsatellites AFLP and RFLP. It performs fast DNA sample screening and high-resolution DNA fragment analysis (2-5bp). The system also analyzes the quality and quantity of total RNA and cRNA, determines the efficiency of cRNA and cDNA amplification reactions and ensures quality of fragmented cRNA. The company sells cartridges that are specific to the type of analysis to be performed. All data is then received in digital form for appropriate transmission and storage.
Park City Group, Inc. announced that it has established a relationship with Del Monte Fresh Produce NA to provide tools and analytics in support of their branded fresh cut fruit program. Del Monte Fresh will utilize Park City Group's analytic tools and professional consulting services to enhance their already successful relationship with their retail customers. Park City Group's Professional Services Division will assist Del Monte Fresh in efforts to provide better quality and freshness for consumers, while delivering improved sales and higher profits for their retail customers.
Del Monte Fresh Produce NA, based in Coral Gables, Florida is one of the world's leading vertically integrated producers, marketers and distributors of high-quality fresh and fresh-cut fruit and vegetables, as well as a leading producer and distributor of prepared fruit and vegetables, juices, beverages, snacks, and desserts in Europe, the Middle East and Africa. Del Monte Fresh Produce Company markets its fresh products worldwide under the Del Monte brand, a symbol of product quality, freshness and reliability since 1892. In FY 2005, Fresh Del Monte Produce reported net sales of over $3.3 billion dollars.
Speaking of the agreement, Randall K. Fields, Park City Group's Chairman and Chief Executive, said, "This is another key milestone for Park City Group and our Professional Services Division. We are experiencing very rapid growth in our Professional Services group and this agreement with Del Monte adds to our momentum. Our Professional Service's staff is unparalleled in their brand and retail management experience, and Del Monte is one of the best known names in the food business. We are proud to be associated with them and their commitment to freshness, quality, and the success of their retail customers."
About OTCStockExchange.com
OTCStockExchange.com (OTCS) is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCS is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCS's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCS provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. OTCS offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.otcstockexchange.com .
We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via email at info*otcstockexchange.com .
OTCStockExchange.com (OTCS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by OTCS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcstockexchange.com or mentioned herein. OTCS has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion.
OTCS sometimes buys or sells public shares of companies profiled in open market transactions, either before, during, or after the publication of a website feature of a company. In the event the trading price of shares in the market place increases, OTCS may profit from the increased value of its holdings.
OTCS has been compensated by third party shareholders or with cash from the company on behalf of MMIO. OTCS has been compensated 50,000 shares on behalf of MMIO for dissemination of this opinion and other professional services.
OTCS's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCS undertakes no obligation to update such statements.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info*m2.com.
(C)1994-2006 M2 COMMUNICATIONS LTD
-0-
Search for Dun & Bradstreet reports on this company.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Frown]](frown.gif)
